98%
921
2 minutes
20
Purpose: Oncodermatology addresses skin conditions caused by cancer or its treatment, which can affect treatment decisions and quality of life. However, electronic health record (EHR)-related communication gaps and appointment wait times hinder timely care. This study assesses the effectiveness of an oncodermatology referral system implemented on March 1, 2023, within a large tertiary healthcare system.
Methods: A centralized email listserv was created to enable oncologists to refer patients with skin complaints for timely care. A retrospective analysis was conducted on 466 patients referred from oncology to dermatology between September 1, 2022, and September 1, 2023. Patients were divided into three groups: Batch 1 (EHR referrals pre-implementation), Batch 2 (EHR referrals only post-implementation), and Batch 3 (all email listserv referrals post-implementation). Key outcomes measured include referral-to-scheduling time, referral-to-appointment time, proportion of underserved patients referred, zip code distribution of referred patients, and success rate of scheduling appointments post-referral.
Results: There was a statistically significant increase in scheduled dermatology appointments post-implementation (Batch 1, 71%; Batch 2, 73%; Batch 3, 88%; P = .0008), as well as significant reductions in referral-to-scheduling (P = 9.82 × 10) and referral-to-appointment times (P = 1.74 × 10). Across Batches 1, 2, and 3, the average referral-to-scheduling time decreased from 19 to 10 to 4 days, while referral-to-appointment time similarly decreased from 51 to 42 to 22 days. Post-implementation, significantly more appointments were created for non-white patients (P < .01) and patients living in peripheral regions within NYC (P < .01).
Conclusion: A centralized email-based oncodermatology referral system significantly improved scheduling efficiency and access for underserved populations, underscoring the importance of streamlined referral processes in improving dermatologic care for cancer patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00520-025-09188-0 | DOI Listing |
Support Care Cancer
February 2025
Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th St, 5th Floor, New York, NY, 10029, USA.
Purpose: Oncodermatology addresses skin conditions caused by cancer or its treatment, which can affect treatment decisions and quality of life. However, electronic health record (EHR)-related communication gaps and appointment wait times hinder timely care. This study assesses the effectiveness of an oncodermatology referral system implemented on March 1, 2023, within a large tertiary healthcare system.
View Article and Find Full Text PDFDermatol Online J
March 2024
Stanford University School of Medicine, Stanford, California, USA.
J Am Acad Dermatol
July 2024
Department of Dermatology, Nice University Hospital, Nice, France. Electronic address:
Background: Studies demonstrating the potential utility of reflectance confocal microscopy (RCM) have been performed under experimental conditions.
Objective: To provide an overview of RCM practice in real-life.
Methods: A multicenter, prospective study carried out in 10 university dermatology departments in France.
J Cancer Res Clin Oncol
July 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Background: Anti-PD1 agents are currently recommended as first-line treatment in advanced cutaneous squamous cell carcinoma (acSCC) by updated European guidelines. Although acSCC frequently affects elderly patients with multiple comorbidities, this subset of patients is often excluded of registration clinical trials.
Purpose: To assess anti-PD-1 efficacy and safety in elderly acSCC patients in real-life conditions and describe this specific population with oncogeriatric evaluation tools.
Support Care Cancer
October 2022
Department of Dermatology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, 02114, USA.